For metastatic lesions, ongoing studies are attempting to take advantage of knowledge gained from the study of tumorigenic mechanisms in SDH-RCC, including VEGF inhibition due to succinate-mediated HIF augmentation. The gene discussed is VEGFA; the disease is renal cell carcinoma.